Megumi Imuta

Title: Megumi Imuta: Innovator in Antitussive Pharmaceutical Composition

Introduction

Megumi Imuta is a notable inventor based in Kawasaki, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antitussive agents. Her innovative work focuses on addressing chronic cough through a unique approach involving activated Factor XI.

Latest Patents

Megumi Imuta holds a patent for a plasma protein effective for suppressing cough. The patent describes activated Factor XI as an antitussive for cough caused by stimulation at the tracheal bifurcation. The pharmaceutical composition aims for the prevention, treatment, and symptom amelioration of cough, comprising a polypeptide chain as an active ingredient and a pharmaceutically acceptable carrier. The polypeptide chain can consist of a full-length amino acid sequence constituting activated Factor XI, with possible modifications such as deletions, substitutions, or additions of amino acids.

Career Highlights

Throughout her career, Megumi has worked with esteemed organizations, including the Chemo-Sero-Therapeutic Research Institute and Ginkgo Academy Kumamoto Health Science University. Her experience in these institutions has contributed to her expertise in pharmaceutical research and development.

Collaborations

Megumi has collaborated with notable colleagues, including Shintaro Kamei and Asami Shindome. These partnerships have fostered a collaborative environment that enhances innovation in her field.

Conclusion

Megumi Imuta's contributions to the pharmaceutical industry, particularly in developing antitussive agents, highlight her role as an influential inventor. Her work continues to pave the way for advancements in cough treatment and showcases the importance of innovation in healthcare.